More Articles

Patients and Medical

PED: Turning the patient voice into a dataset

Andrew Stone, (Apr 3, 2023)

Patients and pharma are teaming up to capture valuable patient experience data and they are only getting started
Multichannel

Making strategic sense of pharma’s new race for competitive advantage 

Andrew Stone, (Mar 16, 2023)

The race for competitive advantage for pharma today is about far more than just innovative new molecules.
Multichannel

Connected HCP experiences: The holy grail of precision marketing

Andrew Stone, (Mar 14, 2023)

Still stuck in multichannel and too often serving up undifferentiated messaging, pharma has much to do to understand and serve individual HCPs
Multichannel

Wired for success in omnichannel

Joseph Constance, (Mar 13, 2023)

Marcomms has much to gain by nurturing a closer working relationship with IT colleagues 
Patients and Medical

Advocacy in hemophilia: Crafting a path that leaves no-one behind 

Clare Jackson, (Feb 8, 2023)

Implementing an ethical and realistic global access strategy for hemophilia so that patients everywhere can receive treatment 
Multichannel

Getting ready for primetime in cell & gene therapy

Clare Jackson, (Dec 8, 2022)

As thousands of novel cell and gene therapies advance along the development pipeline, pressure mounts for scalable treatments
Commercial

Building a commercial dream team for today’s pharma industry

Brian Eastwood, (Dec 7, 2022)

The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams 
Patients and Medical

Digital Health: Letting human nature drive design

Katie Delaney, (Nov 22, 2022)

End users are increasingly important partners in developing digital health solutions, to the benefit of all
Access and Evidence

RWE’s new dataset: Social media

Andrew Stone, (Nov 22, 2022)

Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond
Multichannel

Scaling CGT through automation

Andrew Stone, (Nov 22, 2022)

Delivering on the promise of cell and gene therapies requires significant process improvements to cut manufacturing time and costs

Pages